Wednesday, July 8, 2026

biotech · Neonatal Infections · Locally Advanced / Metastatic Solid Tumors · CBIO

CRESCENT BIOPHARMA

CRESCENT BIOPHARMA trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Waltham, USA HQ
57 Employees
Public company Type
CBIO · NYSE Ticker
Company details
Status
Public
HQ
Waltham, USA
Employees
57
Programs
3
Drugs
5
Patents
2
Intelligence · Clinical Trials

CRESCENT BIOPHARMA clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to CRESCENT BIOPHARMA programs — each row shows trial ID, program name, phase, status, and indication.

CRESCENT BIOPHARMA trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for CRESCENT BIOPHARMA.

  1. Folic acid — Unknown

    Clinical update
  2. Chlorhexidine — Approved

    Clinical update
  3. CR-001 — Phase 2

    Clinical update

Trial registry

3 studies